Cairo – Mubasher: Ibnsina Pharma reported net profits of EGP 50.37 million in the first quarter (Q1) of 2021, slightly up from EGP 50.27 million in the prior-year period.
The sales increased to EGP 4.75 billion in the January-March period, compared to EGP 4.44 billion in the corresponding period a year earlier, the company said in a bourse disclosure on Monday.
In 2020, Ibnsina Pharma recorded net profits of EGP 224.66 million, down from EGP 328.77 million a year earlier, including minority shareholders’ rights.
